Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Scottsdale, Arizona, United States
  • Sedona, Arizona, United States
View all 138 locations
View Trial Details
Completed

Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00407758

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • Evanston Northwestern Healthcare - Evanston Hospital Evanston, Illinois, United States
View all 16 locations
View Trial Details
Completed

A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer

NCT02591095

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • CHU Besançon - Hôpital Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Francois Baclesse Caen, France
  • Centre Oscar Lambret Lille, France
View all 16 locations
View Trial Details
Completed

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01489371

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of New Mexico Cancer Center Albuquerque, New Mexico, United States
View Trial Details
Completed

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

NCT01381861

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Palm Beach Cancer Institute West Palm Beach, Florida, United States
View Trial Details

Related conditions